Inito, an all-in-one fertility monitor, can be a viable option for individuals trying to conceive, as it measures four key fertility hormones instead of one, delivering lab-grade hormone readings from the comfort of their home in about 10 minutes. The device tracks estrogen, LH, FSH, and PdG, providing personalized insights to help identify the six-day fertile window and confirm whether ovulation actually occurred.
Inito differs from standard ovulation tests, which only measure LH, and from cycle apps, which predict based on averages. According to integrative fertility expert Cyntia Onuoha-Brown, PharmD, “Most traditional tools look at one piece of the puzzle,” whereas Inito gives users a full picture of their cycle.
How Inito Works
Inito uses Spectral Mapping technology to detect and distinguish the four different hormones in urine, providing actual hormone values and trend charts. This technology uses both visual colorimetric imaging and fluorescence signals to analyze the test strip, capturing 100× richer information than traditional readers.
Research supports the accuracy of Inito’s hormone tracking, with one study finding a 95% correlation between Inito’s urinary hormone patterns and corresponding serum hormone trends. Additionally, research published in Nature’s Scientific Reports found that Inito confirms ovulation with over 92.2% accuracy.
Related Post: Zap delivers essential health and aged care updates
Inito vs. Traditional Fertility Tracking Methods
Inito compares favorably to traditional fertility tracking methods, such as ovulation predictor kits (OPKs), basal body temperature (BBT) tracking, and cycle apps. While OPKs only measure LH, Inito tracks multiple hormones, providing a more detailed picture of the cycle. BBT tracking, on the other hand, predicts ovulation based on a slight drop in temperature followed by an increase post-ovulation, but can be inconvenient and less accurate.
Inito’s hormone tracking is powered by insights from over 40 million hormone data points, delivering fertility insights personalized to individual hormone levels. This allows Inito to identify the fertile window and confirm ovulation, even in cases of irregular cycles or PCOS.
Expert Insights
Fertility specialists, such as Dr. Lora Shahine, a double board-certified OB/GYN and reproductive endocrinologist, emphasize the importance of looking at the overall pattern of hormone levels, rather than relying on a single data point. Dr. Shahine notes that “Fertility is rarely determined by a single data point—it’s the overall hormonal sequence that provides the most useful information.”
Other experts, such as Dr. Sasha Hakman, a double board-certified OB/GYN and reproductive endocrinology and infertility specialist, highlight the benefits of Inito for patients, including faster and more precise clinical decisions, and better outcomes. Dr. Hakman notes that “The patients who come in with hormone data have fundamentally different appointments than those who come in with just a positive OPK and a date.”
Read Also: Kidney Disease Screening Gains, Early Diagnosis Remains Flat
Real-World User Experiences
Inito users, such as Bailey Blackburn, who had regular periods but unpredictable ovulation timing, have reported success with the device. Blackburn notes that “I ended up having two LH spikes in April, and would have never known had I not been tracking with Inito… it caught my second LH surge, and that’s when we conceived.”
Other users, such as Brooke Gresock, who had four unsuccessful cycles trying for her second child, have also reported success with Inito. Gresock notes that “After the first cycle using Inito, I found out I was not ovulating. I showed my Inito graph to my gynecologist; she tested me further and agreed to start me on medication. The very next medicated cycle, I tracked with Inito, confirmed ovulation, and was pregnant!”
Inito’s user stories highlight the benefits of the device for individuals with complex or variable cycles, including those with PCOS, irregular cycles, or secondary infertility. The device provides a clear picture of hormone levels, allowing users to make more informed decisions about their fertility.
Dr. Shahine notes that the goal should always be to gain clarity, not create more stress. Inito’s ease of use and personalized insights make it a valuable tool for individuals trying to conceive, providing a clear and accurate picture of their hormone levels and fertile window.
Read Also: Ted Lasso offers lessons for doctors
Inito is not suitable for everyone, particularly those currently on hormonal birth control, as the readings may not be accurate. However, for individuals with irregular cycles, PCOS, or those trying to conceive, Inito’s hormone tracking and personalized insights make it a valuable investment.
The device’s accuracy and effectiveness have been demonstrated through research and user experiences.
Moreover, the ability to share Inito charts with healthcare providers can facilitate more informed discussions and decisions, as the charts provide a detailed and accurate representation of an individual’s hormone levels and fertile window. This can be particularly beneficial for individuals with complex fertility issues, as it enables healthcare providers to develop more tailored treatment plans.